The Greenberg Bladder Cancer Institute granted three awards in 2017.
Sexual Function Outcomes and Sexual Dysfunction in Women with Bladder Cancer: a Mixed-Methods Analysis of Patient-Reported Outcomes after Radical Cystectomy for Urothelial Bladder Cancer
 | Sima Porten, MD Department of Urology University of California, San Francisco |
 | Sumeet Bhanvadia, MD Institute of Urology USC Keck School of Medicine |
Dr. Bhandavia (USC) and Dr. Porten (UCSF) will investigate the extent of sexual dysfunction experienced by women after radical cystectomy, and its impact on them and their partners. This will be a multi-site, mixed methods study, that seeks to understand this important domain of quality of life in an in-depth way, with the goal of improving survivorship for women with bladder cancer.
Nuclear receptor-activated transcriptomic signatures in human urothelium for the deconvolution of tumour transcriptomes.
 | Simon Baker, PhD, & Jenny Southgate, PhD Department of Biology University of York |
Although nuclear receptors (NRs) play a key role in regulating urothelial differentiation and the molecular landscape of bladder cancer, the contribution of individual NRs to downstream transcriptional networks is poorly resolved. Here we propose to generate comprehensive transcriptional subnetworks from normal human urothelial cells as a framework from which to identify and target specific cancer-related programs.
Understanding Sexual Dysfunction in Women with Bladder Cancer Undergoing Radical Cystectomy
 | Natasha Gupta, MD Brady Urological Institute Johns Hopkins School of Medicine |
Sexual dysfunction is a significant quality of life issue among women undergoing radical cystectomy for bladder cancer. The purpose of this study is to gain an understanding of the components of sexual health and dysfunction among women undergoing radical cystectomy and to assess variations in national practice patterns among urologists regarding operative techniques that can impact sexual function in women.